Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
Tobias Albrecht, Martin M. Sailer, Flavia Capitani, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 5, pp. 100780-100780
Open Access | Times Cited: 23

Showing 23 citing articles:

Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Marisa Dorling, Juan Carlos Hernaiz‐Leonardo, Athenea Pascual, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3054-3059
Open Access | Times Cited: 14
Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature
Marella Reale, Giuseppe Licci, Pietro Orlando, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 10, pp. 5023-5031
Closed Access | Times Cited: 9
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 3108-3117
Open Access | Times Cited: 6
Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung
Anna-Rebekka Staufenberg, H. Frankenberger, Ulrike Förster‐Ruhrmann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 473-483
Open Access | Times Cited: 5
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
Daiki Nakashima, Tsuguhisa Nakayama, Shunsuke Minagawa, et al.
Journal of Allergy and Clinical Immunology Global (2025) Vol. 4, Iss. 2, pp. 100412-100412
Open Access
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
From one biologic to another: the rationale and evidence behind switching therapies in chronic rhinosinusitis
Baharudin Abdullah, Farah Dayana Zahedi, Pongsakorn Tantilipikorn
Current Opinion in Allergy and Clinical Immunology (2025)
Closed Access
A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months
Giulia Costanzo, Andrea Ledda, Giada Sambugaro, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101041-101041
Open Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months
Pietro Orlando, Giuseppe Licci, Gennaro Illiano, et al.
The Laryngoscope (2025)
Closed Access
Rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis: A systematic review and meta‐analysis
Jenny B. Xiao, Helen Hsiao, Carlos Khalil, et al.
International Forum of Allergy & Rhinology (2024) Vol. 14, Iss. 10, pp. 1618-1633
Open Access | Times Cited: 3
Asthma Phenotypes in the Era of Personalized Medicine
Víctor González-Uribe, Sergio Jesús Romero-Tapia, José A. Castro-Rodrı́guez
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6207-6207
Open Access | Times Cited: 7
Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains
Ignazio La Mantia, Giancarlo Ottaviano, Martina Ragusa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 347-347
Open Access | Times Cited: 1
Trends in dupilumab persistence among patients with chronic rhinosinusitis with nasal polyps
Taylor Stack, Saif Zaidi, Theresa A. Dickerson, et al.
Rhinology online (2024) Vol. 7, Iss. 7, pp. 69-74
Open Access | Times Cited: 1
Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
Paweł Iwańczuk
Journal of Education Health and Sport (2024) Vol. 63, pp. 84-94
Open Access
Efectividad real de la terapia biológica en el tratamiento de pacientes con rinosinusitis crónica con poliposis nasosinusal
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
Canadian Real-World Study Long-Term Clinical Results Using Dupilumab for Chronic Rhinosinusitis With Polyps
Shaun Kilty, Andrea Lasso
Journal of Otolaryngology - Head and Neck Surgery (2024) Vol. 53
Open Access
Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Effect of Treatment with Emphasis on Biological Therapy
Josje Janna Otten, Wytske J. Fokkens, Sietze Reitsma
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access
Biologics in Rhinology
Samy Elwany
(2024), pp. 387-400
Closed Access
Eosinophilic diseases in otorhinolaryngological practice – what is worth to know about new treatment options
Magdalena Arcimowicz
Polski Przegląd Otorynolaryngologiczny (2023) Vol. 12, Iss. 4, pp. 21-31
Closed Access
Page 1

Scroll to top